Fleming TR - Search Results

1

Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.

Decker DG, Fleming TR, Malkasian GD Jr, Webb MJ, Jeffries JA, Edmonson JH. Decker DG, et al. Among authors: fleming tr. Obstet Gynecol. 1982 Oct;60(4):481-7. Obstet Gynecol. 1982. PMID: 6889714 Clinical Trial.

2

Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease.

Edmonson JH, Fleming TR, Decker DG, Malkasian GD, Jorgensen EO, Jefferies JA, Webb MJ, Kvols LK. Edmonson JH, et al. Among authors: fleming tr. Cancer Treat Rep. 1979 Feb;63(2):241-7. Cancer Treat Rep. 1979. PMID: 445503 Clinical Trial.

3

Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomas.

Edmonson JH, McCormack GW, Fleming TR, Cullinan SA, Krook JE, Malkasian GD, Podratz KC, Mailliard JA, Jefferies JA, Barlow JF, et al. Edmonson JH, et al. Among authors: fleming tr. Cancer Treat Rep. 1985 Nov;69(11):1243-8. Cancer Treat Rep. 1985. PMID: 3937598 Clinical Trial.

4

Cyclophosphamide, adriamycin, and cis-diamminedichloroplatinum (II) in the treatment of patients with advanced head and neck cancer.

Creagan ET, Fleming TR, Edmonson JH, Ingle JN, Woods JE. Creagan ET, et al. Among authors: fleming tr. Cancer. 1981 Jan 15;47(2):240-4. doi: 10.1002/1097-0142(19810115)47:2<240::aid-cncr2820470206>3.0.co;2-7. Cancer. 1981. PMID: 7193079

5

Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen.

Creagan ET, Fleming TR, Edmonson JH, Ingle JN, Woods JE. Creagan ET, et al. Among authors: fleming tr. Cancer. 1981 Jun 1;47(11):2549-51. doi: 10.1002/1097-0142(19810601)47:11<2549::aid-cncr2820471105>3.0.co;2-h. Cancer. 1981. PMID: 7196281

6

Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinoma.

Edmonson JH, Fleming TR, Decker DG, Jorgensen EO, Malkasian GD, Jefferies JA, Kvols LK, Webb MJ. Edmonson JH, et al. Among authors: fleming tr. Recent Results Cancer Res. 1978;68:157-9. doi: 10.1007/978-3-642-81332-0_23. Recent Results Cancer Res. 1978. PMID: 752853 No abstract available.

7

Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.

Edmonson JH, Fleming TR, Ivins JC, Burgert EO Jr, Soule EH, O'Connell MJ, Sim FH, Ahmann DL. Edmonson JH, et al. Among authors: fleming tr. J Clin Oncol. 1984 Dec;2(12):1390-6. doi: 10.1200/JCO.1984.2.12.1390. J Clin Oncol. 1984. PMID: 6512582 Clinical Trial.

8

Pulmonary resection for metastatic nonosteogenic sarcoma.

Creagan ET, Fleming TR, Edmonson JH, Pairolero PC. Creagan ET, et al. Among authors: fleming tr. Cancer. 1979 Nov;44(5):1908-12. doi: 10.1002/1097-0142(197911)44:5<1908::aid-cncr2820440553>3.0.co;2-2. Cancer. 1979. PMID: 498056

9

Phase II evaluation of maytansine in patients with advanced head and neck cancer.

Creagan ET, Fleming TR, Edmonson JH, Ingle JN. Creagan ET, et al. Among authors: fleming tr. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2061-2. Cancer Treat Rep. 1979. PMID: 526939 No abstract available.

10

VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.

Eagan RT, Creagan ET, Ingle JN, Rubin J, Frytak S, Kvols LK, Fleming TR. Eagan RT, et al. Among authors: fleming tr. Tumori. 1979 Feb 28;65(1):105-9. doi: 10.1177/030089167906500112. Tumori. 1979. PMID: 442215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page